Evaluation of a model for assessment and treatment of HCV among injecting drug users in opiate pharmacotherapy clinics.

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/568985

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Hepatitis C (HCV) treatment uptake remains extremely low in Australia (2% of 204,000 people with chronic HCV per year). Barriers to HCV treatment are greatest among recovering and current injecting drug users. A large proportion of this population is receiving opiate pharmacotherapy, but few HCV treatment services have been developed in this context. The goal of this project is to evaluate an innovative model for the provision of assessment and treatment of HCV in opiate pharmacotherapy clinics

Funded Activity Details

Start Date: 01-01-2010

End Date: 01-01-2014

Funding Scheme: NHMRC Partnerships

Funding Amount: $1,548,740.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Health And Community Services

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Addiction | Health outcomes | Health policy and services evaluation | Hepatitis C | Opioid dependence

Related Links